1-Phenyl-1,2-propanedione
Common Name: |
1-Phenyl-1,2-propanedione |
IUPAC Name: |
1-phenylpropane-1,2-dione |
Molecular Formula: |
C9H8O2 |
SMILES: |
CC(=O)C(=O)C1=CC=CC=C1 |
Inchi: |
1S/C9H8O2/c1-7(10)9(11)8-5-3-2-4-6-8/h2-6H,1H3 |
Inchi Key: |
BVQVLAIMHVDZEL-UHFFFAOYSA-N |
Cas No: |
579-07-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
148.16 |
Mass (g/mol) |
148.052 |
Molar Refractivity |
41.64 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
34.14 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
18.00 to 19.00 |
Boiling Point (°C@760.00mm Hg) |
222 |
Vapor Pressure (mmHg@25.00 °C) |
0.075 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.11 |
LogP |
1.458 |
iLOGP |
1.02 |
XLOGP3 |
1.72 |
WLOGP |
1.46 |
MLOGP |
1.08 |
ESOL Log S |
-2.11 |
ESOL Solubility (mg/ml) |
1.14 |
ESOL Solubility (mol/l) |
0.008 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.05 |
Ali Solubility (mg/ml) |
1.31 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.66 |
Silicos-IT Solubility (mg/ml) |
0.32 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.98 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.751 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
0.546 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |